Fifth disease - Morbus Quintushttps://en.wikipedia.org/wiki/Fifth_disease
Morbus Quintus (Fifth disease) est una ex multis manifestationibus contagii a parvovirus B19. morbus quintus (fifth disease) communior est inter pueros.

morbus quintus (fifth disease) incipit cum febribus humilibus, cefalalgia, malae dispositionis, symptomatibus similis frigori, sicut nasus fluens vel congestus. Pauca post dies, exanthema apparet. Rubrum exanthema maxime conspicuum est in facie, praesertim in genis (unde nomen “morbus maxillam obduxit”). Praeter genas rubentes, pueri saepe maculam rubram, lacyam, in reliquo corpore, praesertim in brachiis, abdomen, et cruribus, appareat.

Morbus plerumque levissimus est, sed in gravidibus infectio in primo trimestre potest provocare hydrops fetalis, abortum spontaneum.

Curatio
Nulla curatio specifica requiritur; plerumque morbus se resolvit per tempus.

☆ In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
  • XVI MENSTRUALIS Morbus Quintus (Fifth disease) Utraeque genae rubescunt, quasi alapae, et epinyctidas maculopapularis corpori apparent.
  • Utraquc genas Erythema.
  • Corpus quoque praeceps reticulata comitari potest.
  • Hoc proprium est genae bilateralis alapae temerariae ex B19 virus infectionis causatae.
References Fifth disease (parvovirus B19) 35951969 
NIH
Quintus morbus, etiam notus erythema infectiosum, est infectio viralis a parvovirus B19 causata. Praesertim in pueris, inter 4 et 14 annos, occurrit. Signa saepe incipiunt cum febribus levibus, cefalalgia, pharyngite et affectionibus tractus respiratorii. In pueris rubor distinctus in facie, similis “slapped cheeks”, cum eruptione maculosa in corpore, brachiis et cruribus, apparet. In adultis dolor articularis querela communis est, quae post septimanas ab infectione initiali apparere potest. Praeterea, circa 20‑30 % adultorum infectorum parvovirus B19 nullas signa exhibere possunt.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
 Exposure to fifth disease in pregnancy 20008596 
NIH
Periculum transmissionis parvovirus B19 a matre ad infantem est circa 33 %, cum circa 3 % mulierum infectarum difficultates in infantibus experientur. Cum mater ante XX septimanas graviditatis infecta est, possunt occurrere complicationes, ut problemata sanguinis et fluidorum in incremento corporis infantis. Initiandum autem ad hunc morbum est, si aeger parvovirus expositus est, elementa serica IgM examinanda sunt. Si probatio nullam praeteritam expositionem demonstrat sed recentem contagionem indicat, aeger magnam vigilantiam in graviditate requirit, inter regularia ultrasonographica ad reprimendam quaestiones sanitatis infantis.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.